Connection
Murat Gokden to Immunohistochemistry
This is a "connection" page, showing publications Murat Gokden has written about Immunohistochemistry.
|
|
Connection Strength |
|
 |
|
 |
|
1.271 |
|
|
|
-
Brasher OC, Nix JS, Gokden M. Significance of Staining Intensity in Ki-67 Proliferation Index in Meningiomas, and a Critical Review of the Literature on Proliferation Index Assessment. Ann Clin Lab Sci. 2024 Mar; 54(2):170-178.
Score: 0.775
-
Gokden M. If it is Not a Glioblastoma, Then What is it? A Differential Diagnostic Review. Adv Anat Pathol. 2017 Nov; 24(6):379-391.
Score: 0.125
-
Gokden N, Gokden M, Phan DC, McKenney JK. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker. Am J Surg Pathol. 2008 Oct; 32(10):1462-7.
Score: 0.067
-
Cetin N, Dienel G, Gokden M. CD117 expression in glial tumors. J Neurooncol. 2005 Nov; 75(2):195-202.
Score: 0.054
-
Gokden M, Shinde A. Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver. Diagn Cytopathol. 2005 Sep; 33(3):166-72.
Score: 0.054
-
Gokden N, Mukunyadzi P, James JD, Gokden M. Diagnostic utility of renal cell carcinoma marker in cytopathology. Appl Immunohistochem Mol Morphol. 2003 Jun; 11(2):116-9.
Score: 0.046
-
D'Almeida Costa F, Dias TM, Lombardo KA, Raghunathan A, Giannini C, Kenyon L, Saad AG, Gokden M, Burger PC, Montgomery EA, Rodriguez FJ. Intracranial cellular schwannomas: a clinicopathological study of 20 cases. Histopathology. 2020 Jan; 76(2):275-282.
Score: 0.036
-
Gomez-Acevedo H, Patterson JD, Sardar S, Gokden M, Das BC, Ussery DW, Rodriguez A. SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion. BMC Cancer. 2019 Aug 22; 19(1):827.
Score: 0.035
-
Phillips BC, Gokden M, Petersen E. Granulomatous encephalitis due to Balamuthia mandrillaris is not limited to immune-compromised patients. Clin Neurol Neurosurg. 2013 Jul; 115(7):1102-4.
Score: 0.022
-
De Las Casas LE, Gokden M, Baker SJ, Korourian S, Hermonat PL, You H, Miranda RN, Shalkham JE, O'Brien LA, Mukunyadzi P. Malignant melanoma metastatic to the liver. A cytomorphologic comparative study to identify reproducible diagnostic criteria. Acta Cytol. 2004 Jan-Feb; 48(1):32-8.
Score: 0.012
-
Bellone S, Palmieri M, Gokden M, Joshua J, Roman JJ, Pecorelli S, Cannon MJ, Santin AD. Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy. Gynecol Oncol. 2003 Oct; 91(1):231-40.
Score: 0.012
-
Cetin N, Ball K, Gokden M, Cruz NF, Dienel GA. Effect of reactive cell density on net [2-14C]acetate uptake into rat brain: labeling of clusters containing GFAP+- and lectin+-immunoreactive cells. Neurochem Int. 2003 Apr; 42(5):359-74.
Score: 0.011
-
Hameed A, Gokden M, Hanna EY. Fine-needle aspiration cytology of a primary ectopic meningioma. Diagn Cytopathol. 2002 May; 26(5):297-300.
Score: 0.011
-
Santin AD, Bellone S, Gokden M, Palmieri M, Dunn D, Agha J, Roman JJ, Hutchins L, Pecorelli S, O'Brien T, Cannon MJ, Parham GP. Overexpression of HER-2/neu in uterine serous papillary cancer. Clin Cancer Res. 2002 May; 8(5):1271-9.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|